NephroPlus IPO Review: Solid Business or High Risk? (Analysis) 👀 #ipo #finance #stockmarket #shorts

NephroPlus IPO — solid story, strong numbers.
Will you apply? 👀

Nephrocare Health Services (NephroPlus) ka IPO 10–12 December open ho raha hai —
aur healthcare sector me aise high-quality IPOs bahut kam dekhne ko milte hain.

2010 mein Hyderabad ke ek dialysis center se shuru hui company
aaj India + Nepal + Philippines + Uzbekistan me 519 centers chala rahi hai.
Revenue FY23 se FY25 tak 437 → 566 → 755 crore.
Profit FY24: ₹35 crore → now ₹67 crore.
Aur big investors like Motilal Securities, Max Life, Times Group, Enam Group
already upper price band par invest kar chuke hain — ₹136 crore!

Is IPO ke baare me aapka kya view hai?
Comments me zaroor likho 👇

Follow for real, unbiased finance breakdowns ❤️📊

#InvestingSimplified
#ipo2025 #StockMarketIndia #InvestingTips #FinanceReels
#FinancialEducation #EquityMarket #InvestorCommunity #IPOReview
#WealthCreation #FinanceForWomen #IndianStocks #MarketAnalysis
#ValueInvesting #FinanceCreator #InvestmentInsights #BusinessNews
#StockMarketForBeginners #LearnInvesting #HealthcareIPO
#LongTermInvesting #StockMarketReels #FinanceShorts #MoneyTalks
#FinancialFreedomIndia

Видео NephroPlus IPO Review: Solid Business or High Risk? (Analysis) 👀 #ipo #finance #stockmarket #shorts канала Finnomics By Manisha